Universe Pharmaceuticals (NYSE:UPC) Stock Price Down 24.3% – Should You Sell?

Shares of Universe Pharmaceuticals INC (NYSE:UPC) dropped 24.3% during mid-day trading on Thursday . The company traded as low as $0.80 and last traded at $0.81. Approximately 1,201,480 shares changed hands during trading, an increase of 133% from the average daily volume of 515,639 shares. The stock had previously closed at $1.07.

Universe Pharmaceuticals Stock Down 4.8 %

The company has a quick ratio of 1.46, a current ratio of 1.63 and a debt-to-equity ratio of 0.08. The firm has a fifty day moving average price of $3.19 and a 200 day moving average price of $26.92.

Institutional Investors Weigh In On Universe Pharmaceuticals

A hedge fund recently bought a new stake in Universe Pharmaceuticals stock. MML Investors Services LLC acquired a new stake in Universe Pharmaceuticals INC (NYSE:UPC) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 234,260 shares of the company’s stock, valued at approximately $57,000. MML Investors Services LLC owned 6.46% of Universe Pharmaceuticals as of its most recent SEC filing. 0.18% of the stock is owned by institutional investors and hedge funds.

About Universe Pharmaceuticals

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.